Supported by over two decades of international experience in regulatory approval, health-technology-assessment, clinical data generation & commercial sales, Stratarium Sàrl collaborates with innovative technology medtechs to establish awareness and credibility in selected markets, including the complex single-payer UK market
Stratarium seeks to work with recently commercialised or pre-commercial technologies that address a specific clinical need, to then establish real-world-evidence clinical evaluations that generate credibility and near-term commercial opportunities
Stratarium’s unique offering is to invest its own resources and share risk with manufacturers, in exchange for an appropriate return based on agreed objectives
